NICOLE MUSKETT: Open Payments
NPI 1528625969 · MISSOULA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 25 payments from 12 companies in 2025. Trend: 2023 $395 · 2024 $344 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $224 |
| Janssen Biotech, Inc. | 4 | $92 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Ferring Pharmaceuticals Inc. | 2 | $45 |
| Laborie Medical Technologies Corp. | 2 | $37 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| 180 Medical, Inc. | 1 | $24 |
| ACCORD HEALTHCARE, INC. | 1 | $20 |
| Teleflex LLC | 1 | $19 |
| IMMUNITYBIO, INC. | 1 | $18 |
Products named: BOTOX, ERLEADA, KEYTRUDA, ADSTILADRIN, LUPRON DEPOT, QULIPTA, RYBREVANT, GEMTESA.
Industry payments across MT — which companies pay providers there.
